Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

C-RAF mutations confer resistance to RAF inhibitors.

Antony R, Emery CM, Sawyer AM, Garraway LA. C-RAF mutations confer resistance to RAF inhibitors. Cancer Res. 2013 Aug 01; 73(15):4840-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.